Showing 324 results

Filters Content type: News, Editors' picks, About HIV Topic: Drug interactions & pharmacokinetics

Taking two or more different drugs together may result in an alteration in the effectiveness or in the side-effects of one or more of the drugs. Pharmacokinetics (PK) is the study of how a drug is absorbed into the body and distributed in different parts of the body. Pharmacodynamics (PD) is the study of the impact of different concentrations of a drug on the body.

PrEP

Evidence that “on-demand” PrEP taken before and after sex can prevent HIV

Editor's pick
BETA blog
12 September 2016
Drug interactions & pharmacokinetics

University HIV smartphone app receives international award

Editor's pick
University of Liverpool press release
1 September 2016
Hepatitis C treatment

Sofosbuvir/velpatasvir shows high cure rate in HIV/HCV co-infection study

News
21 July 2016
Drug interactions & pharmacokinetics

Sofosbuvir/velpatasvir for hepatitis C can be administered with most antiretrovirals

News
14 March 2016
Transgender people

Transgender people are at high risk for HIV, but too little is known about prevention and treatment for this population

News
11 March 2016
PrEP

Women need more of the HIV drug Truvada than men to prevent infection

Editor's pick
Eurekalert Medicine & Health
4 March 2016
PrEP science

Almost-certain case of PrEP failure due to drug resistance reported at CROI 2016

News
25 February 2016
The search for a cure

Study: HIV can hide and grow in 'sanctuaries' in body after it's undetectable in blood

Editor's pick
Washington Post
28 January 2016
Drug interactions & pharmacokinetics

People taking a large number of non-HIV-related medications more likely to stop or change HIV drugs

News
27 January 2016
Drug interactions & pharmacokinetics

Many patients on new HCV medications at risk of drug-drug interactions

Editor's pick
Medscape (requires free registration)
23 December 2015
Drug interactions & pharmacokinetics

Study reveals potential challenges for scaling up of HCV therapy in UK

News
24 November 2015
Treatment guidelines

How do we maximise global HIV treatment access? IAPAC Care Continuum Guidelines make recommendations

News
9 November 2015
The search for a cure

Oestrogen may block HIV reactivation, hints at gender differences in viral reservoirs

News
8 September 2015
Drug interactions & pharmacokinetics

HIV-treatment 'booster drugs' are most likely to have dangerous interactions with methamphetamine, mephedrone, MDMA and ketamine

News
24 August 2015
Ageing & HIV

Top five concerns people with HIV have about ageing: Scotland

Editor's pick
HIV Scotland-
12 August 2015
PrEP science

Intermittent PrEP may be a robust strategy for anal sex – vaginal much less certain

News
22 July 2015
Ageing & HIV

Geriatric HIV: living with multiple medical conditions will become the norm as population ages

News
16 June 2015
Drug interactions & pharmacokinetics

'Lab on a card' can spot poor quality drugs

Editor's pick
BBC Health
8 June 2015
Drug interactions & pharmacokinetics

Almost Three Quarters of HIV/HCV Group May Have DDA-ARV Interactions

Editor's pick
NATAP
2 June 2015
Kidney problems

Lower daily tenofovir dose of 150mg safe and effective in people with moderate renal impairment

News
22 May 2015
Hepatitis C treatment

Sofosbuvir/ledipasvir raises some antiretroviral levels in HIV/HCV coinfected people

News
10 March 2015
Drug interactions & pharmacokinetics

Isentress (raltegravir) label update

Editor's pick
FDA
19 February 2015
HIV treatment

Viral Load Reductions Persist With Less Efavirenz for HIV

Editor's pick
Medscape (requires free registration)
7 November 2014
Contraception

Efavirenz compromises hormonal contraceptive implant

News
3 November 2014